January 8, 2018 / 12:31 PM / 6 months ago

BRIEF-Acorda Therapeutics Sees FY 2018 Sales $330 Mln To $350 Mln For AMPYRA

Jan 8 (Reuters) - Acorda Therapeutics Inc:

* ACORDA ANNOUNCES 2017 AMPYRA NET SALES AND PROVIDES 2018 FINANCIAL GUIDANCE AT J.P. MORGAN HEALTHCARE CONFERENCE

* SEES FY 2018 SALES $330 MILLION TO $350 MILLION FOR AMPYRA

* INBRIJA NDA RESUBMITTED IN DECEMBER 2017; INITIAL FDA RESPONSE EXPECTED IN FEBRUARY 2018

* YEAR-END CASH BALANCE FOR 2018 IS PROJECTED TO BE OVER $300 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below